Director, Information Technology - Boston, United States - Page Mechanical Group Inc

    Page Mechanical Group Inc
    Page Mechanical Group Inc Boston, United States

    4 weeks ago

    Default job background
    Description


    TheDirector, Information Technology (IT) Systems will collaborate with the VP, IT to provide the strategic framework for validation, management, and support of GxP-regulated systems and implement against the strategy in collaboration with stakeholders.


    The Director, IT Systems will work with Quality, R&D, Clinical, and Compliance stakeholders to map out short and long term strategies related to supporting the systems already in use or needed during the next 3-5 years.

    This includes procuring, validating, maintaining, and supporting these systems along with potentially migrating legacy content, where appropriate.

    The Director, IT Systems reports to the VP, IT.


    Job Responsibilities:
    Partner with stakeholders providing SME guidance and support for Quality, R&D, Clinical, and Compliance systems.

    Collaborate with teams regarding short and long term needs for Quality, R&D, Clinical, and Compliance systems.

    Collaborate with teams to analyze and develop plans to streamline business process.


    Collaborate with business to develop strategies for investigating, implementing, validating, and supporting new systems aligned to business requirements the next 3-5 years (eTMF, RIMS, SAP, etc).

    Collaborate with business management and VP, IT on forecasting/budgeting.

    Ensure proper validation, maintenance, and support of GxP regulated systems.

    Ensure GxP systems adhere to computer systems validation processes and procedures.

    Ensure documentation and policies are maintained. Systems and solutions are well documented, inventoried, and compliant with regulatory, technical, and operational standards, policies, and procedures.

    Ensure change controls are strictly adhered to for regulated systems.

    Establish and implement a validated systems approaches for GxP data.

    Provide oversight to vendors/consultants providing systems or services support to GxP-regulated systems (e.g. Veeva) ensuring services provided are meeting/exceeding expectations.

    Provide SME support to Quality Assurance for IT related audits (e.g. qualification/re-qualification audits).

    Support regulatory compliance including SOX, CFR Part 11, GDPR, and others as required.

    Staying updated on advancements in the fields of IT systems to advise businesses and clients on industry best practices.


    Skills, Qualifications, and Requirements:
    Bachelor of Science or comparable experience preferred.

    Minimum of 5 years' experience in IT Quality and Compliance oriented roles.

    Minimum of 3 years' experience in validating regulated products.

    Deep experience and working knowledge of Quality, R&D, Clinical, and Compliance systems.

    Hands on, working knowledge of Veeva platform required.

    Excellent project management knowledge and skills.

    Hands on experience documenting policies and procedures in a regulated, pharmaceutical, environment.

    Extensive experience working cross-functionally, building collaborative working relationships and interfacing effectively with all levels of the business.

    Good presentation skills in both the creation and delivery of presentations to large and small teams of people.

    Excellent written and verbal communication skills.

    Strong leadership, influencing, negotiation, and planning skills.

    Ability to adjust quickly to changing priorities and conditions and to cope effectively with complexity and change.

    Fosters a positive and collaborative work environment.

    Willing to work in Boston 3 days per week.

    AVEO Oncology ("AVEO") is an oncology-focused biopharmaceutical company committed to providing innovative solutions to improve cancer patients lives. On January 20, 2023, AVEO was acquired by LG Chem, Ltd. ("LG Chem"), establishing a U.S. commercial presence for LG Chem and expanding LG Chem's global oncology portfolio. AVEO continues to commercialize FOTIVDA (tivozanib) in the U.S. To learn more about FOTIVDA efficacy, safety, and relevant resources, visit

    .

    #J-18808-Ljbffr